Answer
In patients with chronic renal failure, intravenous darbepoetin alfa has a terminal half-life of 21 hours (standard deviation 7.5 hours).
Sources for this answer
- Aranesp solution for injection in pre-filled syringe / Aranesp solution for injection in pre-filled syringe with needle guardAmgen Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 1Document updated
Sources checked